Next Financial Group’s Takeda Pharmaceutical TAK Stock Holding History

Next Financial Group’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$9K	Sell	626 -65	-9%	-$912	﹤0.01%	2237
2021 Q3	$11K	Sell	691 -13	-2%	-$218	﹤0.01%	2010
2021 Q2	$12K	Sell	704 -64	-8%	-$1.09K	﹤0.01%	1930
2021 Q1	$14K	Sell	768 -173	-18%	-$3.11K	﹤0.01%	1772
2020 Q4	$17K	Buy	941 +519	+123%	+$9.11K	﹤0.01%	1615
2020 Q3	$8K	Buy	+422	New	+$7.68K	﹤0.01%	1700
2020 Q2	–	Sell	-452	Closed	-$7K	–	1756
2020 Q1	$7K	Buy	452 +422	+1,407%	+$7.65K	﹤0.01%	1632
2019 Q4	$1K	Sell	30 -125	-81%	-$2.39K	﹤0.01%	2302
2019 Q3	$3K	Hold	155	–	–	﹤0.01%	2042
2019 Q2	$3K	Sell	155 -410	-73%	-$7.46K	﹤0.01%	2044
2019 Q1	$12K	Buy	+565	New	+$11.4K	﹤0.01%	1080

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BCP

BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Next Financial Group's TAK Position: Q4 2021 in Review

Next Financial Group reduced its Takeda Pharmaceutical (TAK) stake by 9.4% in Q4 2021, selling an estimated $912 and leaving 626 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

Next Financial Group first reported a position in TAK in Q1 2019 and has held it in 11 quarters since. The position peaked at $17K in Q4 2020. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

Next Financial Group held 626 shares of Takeda Pharmaceutical worth $9K as of Q4 2021.
Next Financial Group sold 65 Takeda Pharmaceutical shares in Q4 2021, an estimated $912.
Takeda Pharmaceutical made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2237 holding.
Next Financial Group first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 11 quarters since.
Next Financial Group's Takeda Pharmaceutical position peaked at $17K in Q4 2020.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.